SNS 032
Tocris Bioscience, part of Bio-Techne | Catalog # 4075
Cdk inhibitor; potently inhibits cdk2, cdk7 and cdk9
Key Product Details
Description
Cdk inhibitor; potently inhibits cdk2, cdk7 and cdk9
Alternative Names
BMS-387032
Product Description
SNS 032 is a cyclin dependent kinase (cdk) inhibitor (reported IC50 values are 0.004 - 0.048, 0.0045 - 0.05, 0.062 - 0.29, 0.2-0.48, 0.4 and 0.45 μM for cdk9, cdk2, cdk7, cdk1, cdk5 and cdk4, respectively). Displays no activity against 190 additional kinases (IC50 >1 μM). Arrests the cell cycle at G2/M; inhibits transcription, proliferation and colony formation, and induces apoptosis in RPMI-8226 multiple myeloma cells. Prevents tumor cell-induced VEGF secretion and in vitro angiogenesis.Product Specifications
Molecular Weight
380.53
Formula
C17H24N4O2S2
Storage
Store at -20°C
Purity
≥98% (HPLC)
Chemical Name
N-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4-piperidinecarboxamide
CAS Number
345627-80-7
PubChem ID
3025986
InChI Key
OUSFTKFNBAZUKL-UHFFFAOYSA-N
SMILES
CC(C)(C)C1=CN=C(CSC2=CN=C(NC(C3CCNCC3)=O)S2)O1
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 19.03 | 50 |
Preparing Stock Solutions
for SNS 032
The following data is based on the product molecular weight 380.53
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.5 mM | 5.26 mL | 26.28 mL | 52.56 mL |
| 2.5 mM | 1.05 mL | 5.26 mL | 10.51 mL |
| 5 mM | 0.53 mL | 2.63 mL | 5.26 mL |
| 25 mM | 0.11 mL | 0.53 mL | 1.05 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Jorda How selective are pharmacological inhibitors of cell-cycle-regulating cyclin-dependent kinases? J.Med.Chem. 2018 PMID: 30234987
- Chen Responses in mantle cell lymphoma cells to SNS-032 depend on the biological context of each cell line. Cancer Res. 2010 PMID: 20663900
- Ali SNS-032 prevents tumor cell-induced angiogenesis by inhibiting vascular endothelial growth factor. Neoplasia 2007 PMID: 17534442
- Conroy SNS-032 is a potent and selective CDK 2, 7 and 9 inhibitor that drives target modulation in patient samples. Cancer Chemother.Pharmacol. 2009 PMID: 19169685
- Misra N-(Cycloalkylamino)acyl-2-aminothiazole inhibitors of cyclin-dependent kinase 2. N-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4- piperidinecarboxamide (BMS-387032), a highly efficacious and selective antitumor agent J.Med.Chem. 2004 PMID: 15027863
Product Specific Notices for SNS 032
For research use only
Loading...
Loading...